Eton Pharmaceuticals, Inc.
ETON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001710340
In the last 90 days, Eton Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $722.6M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Eton Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +1 vs. Q1 2024
- Shares held
- 8.72M
- +1.05M (+13.6%) vs. Q1 2024
- Total value
- $28.7M
- −$91.4K (−0.3%) vs. Q1 2024
- New holders
- 7
- 6 more added
- Sold out
- 6
- 16 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 164 | $722.6M |
| Q1 2026 | 116 | $438.6M |
| Q4 2025 | 104 | $277.5M |
| Q3 2025 | 103 | $394.7M |
| Q2 2025 | 87 | $243.3M |
| Q1 2025 | 86 | $189.7M |
| Q4 2024 | 71 | $181.5M |
| Q3 2024 | 48 | $60.0M |
| Q2 2024 | 45 | $28.7M |
| Q1 2024 | 44 | $28.8M |
| Q4 2023 | 56 | $33.5M |
| Q3 2023 | 50 | $28.8M |
| Q2 2023 | 33 | $20.9M |
| Q1 2023 | 35 | $22.5M |
| Q4 2022 | 31 | $18.2M |
| Q3 2022 | 32 | $14.4M |
| Q2 2022 | 29 | $14.6M |
| Q1 2022 | 31 | $27.4M |
| Q4 2021 | 32 | $24.1M |
| Q3 2021 | 37 | $29.5M |
| Q2 2021 | 46 | $48.1M |
| Q1 2021 | 50 | $63.7M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Eton Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lindbrook Capital, LLC | 4 | $13 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 4 | $14 | 0.00% | −44,610−100.0% | Reduced |
| Citadel Advisors LLC | 32 | $105 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 183 | $602 | 0.00% | +183 | New |
| Morgan Stanley | 192 | $632 | 0.00% | +154+405.3% | Added |
| Advisor Group Holdings, Inc. | 300 | $987 | 0.00% | +300 | New |
| BNP Paribas Arbitrage, SA | 350 | $1.15K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 747 | $2.00K | 0.00% | −18−2.4% | Reduced |
| Plante Moran Financial Advisors, LLC | 1,000 | $3.29K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 1,200 | $3.95K | 0.00% | +1,200 | New |
| Tower Research Capital LLC (TRC) | 3,638 | $12.0K | 0.00% | −3,955−52.1% | Reduced |
| Raymond James & Associates | 10,250 | $33.7K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 10,564 | $34.8K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,018 | $36.2K | 0.00% | +9,058+462.1% | Added |
| Quantum Private Wealth, LLC | 11,500 | $37.8K | 0.01% | 00.0% | Unchanged |
| XTX Topco Ltd | 11,739 | $38.6K | 0.00% | −2,364−16.8% | Reduced |
| Charles Schwab Investment Management Inc | 13,239 | $43.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 16,485 | $54.2K | 0.00% | −15,305−48.1% | Reduced |
| Chicago Trust Co NA | 16,700 | $54.9K | 0.01% | 00.0% | Unchanged |
| Essex Investment Management Co LLC | 27,252 | $89.7K | 0.02% | −51,361−65.3% | Reduced |
| Blair William & Co | 34,500 | $113.5K | 0.00% | −2,479−6.7% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 34,847 | $114.6K | 0.00% | −4,450−11.3% | Reduced |
| Squarepoint Ops LLC | 41,255 | $135.7K | 0.00% | −7,838−16.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 50,917 | $167.5K | 0.00% | −45,952−47.4% | Reduced |
| Goldman Sachs Group Inc | 57,503 | $189.2K | 0.00% | −61,352−51.6% | Reduced |
| Northern Trust Corp | 59,849 | $196.9K | 0.00% | −1,281−2.1% | Reduced |
| Bank of New York Mellon Corp | 74,491 | $245.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 81,403 | $267.8K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 106,500 | $350.4K | 0.00% | +41,469+63.8% | Added |
| Stonepine Capital Management, LLC | 110,000 | $361.9K | 0.33% | +110,000 | New |
| Acadian Asset Management LLC | 120,574 | $395.0K | 0.00% | −35,812−22.9% | Reduced |
| Thompson Siegel & Walmsley LLC | 127,724 | $420.0K | 0.01% | +127,724 | New |
| Susquehanna International Group, LLP | 134,288 | $441.8K | 0.00% | −64,931−32.6% | Reduced |
| Aristides Capital LLC | 200,000 | $658.0K | 0.27% | +200,000 | New |
| Geode Capital Management, LLC | 240,331 | $790.9K | 0.00% | +6,164+2.6% | Added |
| Parkman Healthcare Partners LLC | 253,197 | $833.0K | 0.11% | +54,029+27.1% | Added |
| Bridgeway Capital Management, LLC | 253,362 | $833.6K | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 282,389 | $929.1K | 0.00% | −563−0.2% | Reduced |
| Paradigm Capital Management Inc | 300,000 | $987.0K | 0.04% | 00.0% | Unchanged |
| National Philanthropic Trust | 492,112 | $1.62M | 0.03% | 00.0% | Unchanged |
| Acuitas Investments, LLC | 579,960 | $1.91M | 1.02% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 585,400 | $1.93M | 0.44% | +11,440+2.0% | Added |
| Nantahala Capital Management, LLC | 940,733 | $3.10M | 0.31% | +940,733 | New |
| Vanguard Group Inc | 1,027,688 | $3.38M | 0.00% | 00.0% | Unchanged |
| Opaleye Management Inc. | 2,395,000 | $7.88M | 1.80% | −50,781−2.1% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −23,078−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −19,155−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −17,700−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −1,848−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,425−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −576−100.0% | Sold out |